THE APPEARENCE OF PROINFLAMMATORY CYTOKINES IN TEMPOROMANDIBULAR JOINT DISORDERS AFTER ARTHROCENTESIS AND LAVAGE
![]() |
Kim, Cheol-Hun
(Department of Oral and Maxillofacial Surgery, College of Medicine, Dong-A University)
Hwang, Hie-Sung (Department of Oral and Maxillofacial Surgery, College of Medicine, Dong-A University) Shin, Sang-Hoon (Department of Oral and Maxillofacial Surgery, College of Dentistry, Busan National University) Chung, In-Kyo (Department of Oral and Maxillofacial Surgery, College of Dentistry, Busan National University) Hwang, Tae-Ho (Department of Pharmacology and MRCMT, College of Medicine, Dong-A University) |
1 | McNeill C: Temporomandibular disorders-guidelines for classification, assessment and management. Chicago, IL: Quintessesce Books, 1993 |
2 | Appelgren A, Appelgren B, Kopp S: Substance P-Associated Increase of Intra-articular Temperature and Pain Threshold in the Arthritic TMJ. J Orofacial Pain 1998;12(2):101-107 |
3 | Whiteside TL: Cytokine measurements and interpretation of cytokine assays in human disease. J Clin Immunol 1994;14:327-339 DOI PUBMED ScienceOn |
4 | Scapino R: Histopathology associated with malposition of the human temporomndibular joint disc. Oral Surg Oral Med Oral Pathol 1983;55:382-397 DOI ScienceOn |
5 | Fu K, Ma X, Zhang Z: Tumor necrosis factor in synovial fluid in patients with temporomandibular disorders. J Oral Maxillofac Surg 1995;53:424-426 DOI ScienceOn |
6 | Nordahl S, Alstergren P, Appelgren A, Appelgren B, Eliasson S, Kopp S: Pain, tenderness, reduced mobility and anterior open bite in relation to radiographic change in temporomandibular disease. Acta Odontol Scand 1997;55:18-22 DOI ScienceOn |
7 | Hogquist KA, Unanue ER, Chaplin DD: Release of IL-1 from mononuclear phagocytes. J Immunol 1989;147:2181-2186 |
8 | Onsten I, Bengner U, besjakov J: Socket migration after Nharnley arthroplasty in rheumatoid arthirtis and osteoarthritis. J Bone Joint Surg 1993;75B:677-680 |
9 | Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH: The pivotal role of tumor necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 1992;107:660-664 DOI ScienceOn |
10 | Guerne P, Zuraw B, Vaughn J: synovium as a source of interleukin-6 in vitro. J Clin Invest 1989;83:585-589 DOI ScienceOn |
11 | Smith JB, Bocchicri MH, Shcrbin AL: Occurrence of interleukin-1 in human synovial fluid: detection by RIA, bioassay and presence of bioassay-inhibiting factors. Rheumatol Int 1989;9:53-58 DOI ScienceOn |
12 |
Campbell I, Piccoli DS, RobertsMJ, Muirden KD, Hamilton JA: Effects of Tumor necrosis factor |
13 | Verbruggen G, Veys EM, Malfait AM, De Clerq L, Vanden Bosch F, de Vlam K: Influence of human recombinant interleukin-1 beta on human articular cartilage. Microactivity and proteoglycans metabolism. Clin Exp Rheumatol 1991;9:481-488 |
14 | Takahashi T, Kondoh T, Fukuda M, Yamazaki Y, Toyosaki T, Suzuki R: Proinflammatory cytokines detectable in synovial fluids from patients with tempormandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol 1998;85:135-141 DOI ScienceOn |
15 | William AC, Daniel M: Long term evaluation of arthrocentesis for the treatment of internal derangement of the temporomandibular joint. J Oral Maxillofac surg 2000;58:852-855 DOI ScienceOn |
16 | Wilkes C: Arthrography of the temporomandibular joint in patients with the TMJ pain dysfunction syndrome. Minn Med 1978;61:645-652 |
17 |
Shafer DM, Assael L, White LB: Tumor necrosis factor- |
18 | Nodahl S, Alstergren P, Kopp S: Tumor necrosis factor alpha in synovial fluid and plasma from patients with chronic connective tissue disease and its relation to temporomandibular joint pain. J Oral Maxillofac Surg 2000;58:525-530 DOI ScienceOn |
19 | Schultz D, Arnold P: Properties of four acute phase proteins: CReactive protein, serum amlyoid protein, alpha-1 acid glycoprotein and fibrinogen. Arthritis Rheum 1990;20:129-147 DOI ScienceOn |
20 | Montai M, GuptaMK, Donlon B: Expression of interleukin-6 in osteoarthritic chondrocyte and effects of fluid-induced shear on this expression in normal human chondrocytes in vitro. J Orthop Res 1990;14:67-73 DOI |
21 | Westacott C, Sharif M. Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 1996;25:254-272 DOI ScienceOn |
22 | Israel HA, Saed-Nejad F. Ratcliffe A: Early diagnosis of osteoarthrosis of the temporomandibular joint: Correlation between arthroscopic diagnosis and keratan sulfate levels in the synovial fluid. J Oral Maxillofac Surg 1991;49:708-711 DOI |
23 | Hopkins SI, Hmphreys M, Jayson MIV: Cytokines in synovial fluid I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol 1988;72:422-427 |
24 | Kamada A, Fujita A, Kakudo K: Changes in the synovial fluid Nacetyl- beta-glucosaminodase activity in the human temporomandibular joint with dysfunction. J Osaka Dent Univ 1993;27:107-111 |
25 | Nordahl S, Alstergren P, Eliasson S, Kopp S: Interleukin-1 beta in plasma and synovial fluid in relation to radiographic changes in arthritic temporomandibular joints. Eur J Oral Sci 1998;106:559-563 DOI PUBMED ScienceOn |
26 | Montgomery MT, Gordon SM, Van Sickels JE, Harms SE: Changes in signs and symptoms following temporomandibular joint disc repositioning surgery. J Oral Maxillofac surg 1992;50:320-328 DOI ScienceOn |
27 | Dolwick MF: Is there a role for temporomandibular joint surgery? Br J Oral Maxillofac Surg 1994;32:307-313 DOI ScienceOn |
28 | Sandler NA, Burklery MJ, Cillo JE: Correlation of inflammatory cytokines with arthroscopic findings in patients with temporomandibular joint internal derangement. J Oral Maxillofac Surg 1988;56:534-543 DOI ScienceOn |
29 | Gustavo Z, Stephen B, Milam, John P, Schimitz: Elution of proteins by continuous temporomandibular joint arthrocentesis. J Oral Maxillofac Surg 1997;55;703-716 |
30 | Ferreira SH, Lorenzetti BB, Bristow AF, Poole S: Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 1988;334:698-700 DOI ScienceOn |
31 | Stegena B, deBont LGM, Boering G: Ostooarthrosis as the cause of craniomandibular pain and dysfunction: A unifying concept. J Oral Maxillofac surg 1989;47:249-256 DOI ScienceOn |
32 | Feldmann M, Brennan FM, Field M, Maini RN: Pathogenesis of rheumatoid arthritis: Cellular and cytokine interactions. In: Smolen JS, Kalden JR, Maini RN(eds). Rheumatoid Arthritis. Berlin, Heidelberg: SpringerVerlag, 1992;41-54 |
33 | Bertazzlol N, Punzi L, Stefani MP: Interrelationships between interleukin (IL)-1, IL-6 and IL-8 in synovial fluid of various arthropathies. Agents Actions 1994;41:90-92 DOI ScienceOn |
34 | American Dental Association: Report of the President's conference on the examination, diagnosis and management of temporomandibular disorders. J Am Dent Assoc 1988;66:75-77 |
35 | Okeson JP: Long term treatment of disk-interference disorders of the temporomandibular joint with anterior repositioning occlusal splints. J Prosthet Dent 1988;60: 611-615 DOI PUBMED ScienceOn |
36 | Manolagas SC: Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000;21:115-137 DOI PUBMED ScienceOn |
37 | Gustavo Z, Stephen B. Milam P: Elution of proteins by continuous temporomandibular joint arthrocentesis. J Oral Maxillofac Surg 1997;55:703-716 |
38 | Kubota E, Imamura H, Kubota T, Shibata T, Murakami K: Interleukin-1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J oral Maxillofac Surg 1997;55:20-27 DOI ScienceOn |
39 | Nitzan DW, Dolwick FM, Heft M: Arthroscopic lavage and lysis of the temporomandibular joint. A change in the perspective. J Oral Maxillofac Surg 1990;48:798-801 DOI ScienceOn |
40 | Shinmei M, Okada Y, Masuda K: The mechanism of cartilage degradation in osteoarthritic joints. Semin Arthritis Rheum 1990;19:16-20 DOI ScienceOn |
41 | Dolwick MF, Katzberg RW, Helm CA: Arthrotomographic evaluation of the temporomandibular joint. J Oral Maxillofac Surg 1979;37:793-799 |
42 | Yih WY: Pathology of arthroscopic tissue of the temporomandibular joint. Oral Maxillofac Surg Clin North Am 1989;1:85-92 |
43 | Nitzan DW, Dolwick MF, Martinez GA: Temporomandibular joint arthrocentesis: A simplified method of treatment for severe limited mouth opening. J Oral Maxillofac Surg 1991;49:1163-1169 DOI ScienceOn |
44 | Aghabeigi B, Henderson B. Hopper C: Temporomandibular joint synovial fluid analysis. Br J Oral Maxillofac Surg 1993;31:15-20 DOI ScienceOn |
45 | Jeanjean AP, Moussaoui SM, Maloteaux JM, Laduron PM: Interleukin-1 beta induces long-term increase of axonally transported opiate receptors and substance P. Neurosci 1995;68:151-157 DOI PUBMED ScienceOn |
46 | Giuliani N, Pedrazzoni M, passeri G, Girasole G: Bisphosphonates inhibit IL-6 production by human osteoblast-like cells. Snand J Rheumatol 1998;27:38-41 DOI ScienceOn |
47 | Fu K, Ma X, Zhang Z: Interleukin-6 in synovial fluid and HLA-DR expression in synovium from patients with temporomandibular disorders. J Orofacial Pain 1995;9:131-137 |
48 | Nancy LC, Edith EB, Kathleen CL, Asgeir S, Shelley B, Karen G, William M: Temporomandibular disorder and optimism: relationships to ischemic pain sensitivity and interleukin-6. Pain 2002;100:99-110 DOI PUBMED ScienceOn |
49 |
Smith RJ, Justen JM, Ulrich RG: Induction of neutral proteinase and prostanoid production in bovine nasal chondrocytes by interleukin-1 and tumor necrosis factor |
50 | Montai M, Gupta MK, Donlon B: Expression of interleukin-6 in osteoarthritic chondrocytes and effects of fluid-induced shear on this expression in normal human chondrocytes in vitro. J Orthop Rex 1996;14:67-73 DOI |
51 | Yoshihara Y, Obata K, Fujimoto N: Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinase-1in sera from patients with rheumatoid arthtitis. Arthritis Rheum 1995;38:969-975 DOI ScienceOn |
![]() |